242 related articles for article (PubMed ID: 26383765)
1. Biotherapies in large vessel vasculitis.
Pazzola G; Muratore F; Pipitone N; Salvarani C
Rev Med Interne; 2016 Apr; 37(4):274-8. PubMed ID: 26383765
[TBL] [Abstract][Full Text] [Related]
2. Standard and biological treatment in large vessel vasculitis: guidelines and current approaches.
Muratore F; Pipitone N; Salvarani C
Expert Rev Clin Immunol; 2017 Apr; 13(4):345-360. PubMed ID: 28116918
[TBL] [Abstract][Full Text] [Related]
3. Biotherapies in large vessel vasculitis.
Ferfar Y; Mirault T; Desbois AC; Comarmond C; Messas E; Savey L; Domont F; Cacoub P; Saadoun D
Autoimmun Rev; 2016 Jun; 15(6):544-51. PubMed ID: 26883459
[TBL] [Abstract][Full Text] [Related]
4. [Recent advances in the treatment of large vessel vasculitides].
Szabó MZ; Kiss E
Orv Hetil; 2017 Jan; 158(1):5-12. PubMed ID: 28067080
[TBL] [Abstract][Full Text] [Related]
5. Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature.
Kötter I; Henes JC; Wagner AD; Loock J; Gross WL
Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S114-29. PubMed ID: 22640655
[TBL] [Abstract][Full Text] [Related]
6. Biological treatments in giant cell arteritis & Takayasu arteritis.
Samson M; Espígol-Frigolé G; Terrades-García N; Prieto-González S; Corbera-Bellalta M; Alba-Rovira R; Hernández-Rodríguez J; Audia S; Bonnotte B; Cid MC
Eur J Intern Med; 2018 Apr; 50():12-19. PubMed ID: 29146018
[TBL] [Abstract][Full Text] [Related]
7. Tocilizumab: a new therapy for large vessel vasculitis.
Al-Homood IA
Clin Exp Med; 2014 Nov; 14(4):355-60. PubMed ID: 23949338
[TBL] [Abstract][Full Text] [Related]
8. 2018 Update of the EULAR recommendations for the management of large vessel vasculitis.
Hellmich B; Agueda A; Monti S; Buttgereit F; de Boysson H; Brouwer E; Cassie R; Cid MC; Dasgupta B; Dejaco C; Hatemi G; Hollinger N; Mahr A; Mollan SP; Mukhtyar C; Ponte C; Salvarani C; Sivakumar R; Tian X; Tomasson G; Turesson C; Schmidt W; Villiger PM; Watts R; Young C; Luqmani RA
Ann Rheum Dis; 2020 Jan; 79(1):19-30. PubMed ID: 31270110
[TBL] [Abstract][Full Text] [Related]
9. Changes in the molecular profiles of large-vessel vasculitis treated with biological disease-modifying anti-rheumatic drugs and Janus kinase inhibitors.
Matsumoto K; Suzuki K; Takeshita M; Takeuchi T; Kaneko Y
Front Immunol; 2023; 14():1197342. PubMed ID: 37197652
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostics and treatment of large vessel vasculitis].
Bauer CJ; Schäfer VS
Inn Med (Heidelb); 2024 Feb; 65(2):107-113. PubMed ID: 38240814
[TBL] [Abstract][Full Text] [Related]
11. Reducing the Toxicity of Long-Term Glucocorticoid Treatment in Large Vessel Vasculitis.
Palmowski A; Buttgereit F
Curr Rheumatol Rep; 2020 Oct; 22(12):85. PubMed ID: 33047263
[TBL] [Abstract][Full Text] [Related]
12. Comparing treatment options for large vessel vasculitis.
Macaluso F; Marvisi C; Castrignanò P; Pipitone N; Salvarani C
Expert Rev Clin Immunol; 2022 Aug; 18(8):793-805. PubMed ID: 35714219
[TBL] [Abstract][Full Text] [Related]
13. Biologic treatment of large-vessel vasculitides.
Schäfer VS; Zwerina J
Curr Opin Rheumatol; 2012 Jan; 24(1):31-7. PubMed ID: 22089099
[TBL] [Abstract][Full Text] [Related]
14. Novel therapeutic strategies for large vessel vasculitis.
Koening CL; Langford CA
Rheum Dis Clin North Am; 2006 Feb; 32(1):173-86, xi. PubMed ID: 16504829
[TBL] [Abstract][Full Text] [Related]
15. [Large vessel vasculitis].
Weigand S; Fleck M
Z Rheumatol; 2014 Jun; 73(5):447-55; quiz 456-7. PubMed ID: 24924731
[TBL] [Abstract][Full Text] [Related]
16. Factors Associated with Relapse and Dependence on Glucocorticoids in Giant Cell Arteritis.
Dumont A; Parienti JJ; Delmas C; Boutemy J; Maigné G; Martin Silva N; Sultan A; Planchard G; Aouba A; de Boysson H
J Rheumatol; 2020 Jan; 47(1):108-116. PubMed ID: 30877210
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in the clinical management of giant cell arteritis and Takayasu arteritis.
Koster MJ; Matteson EL; Warrington KJ
Curr Opin Rheumatol; 2016 May; 28(3):211-7. PubMed ID: 26885650
[TBL] [Abstract][Full Text] [Related]
18. Treatment and outcomes of large vessel arteritis.
Borg FA; Dasgupta B
Best Pract Res Clin Rheumatol; 2009 Jun; 23(3):325-37. PubMed ID: 19508941
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of leflunomide in the management of large vessel vasculitis: A systematic review and metaanalysis of cohort studies.
Narváez J; Estrada P; LLop D; Vidal-Montal P; Brugarolas E; Maymó-Paituvi P; Palacios-Olid J; Nolla JM
Semin Arthritis Rheum; 2023 Apr; 59():152166. PubMed ID: 36645992
[TBL] [Abstract][Full Text] [Related]
20. Medium- and Large-Vessel Vasculitis.
Saadoun D; Vautier M; Cacoub P
Circulation; 2021 Jan; 143(3):267-282. PubMed ID: 33464968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
